Different Finite Durations of Anticoagulation and Outcomes following Idiopathic Venous Thromboembolism: A Meta-Analysis

李美娟、余聰、蘇慧真（2019）。Systemic review and meta-analysis of direct oral anticoagulants in patients with venous thromboembolism。台灣實證醫學學會會刊，10(2)，25-40。https://doi.org/10.6864/EC.201912_10(2).0010
Yang, C. A. (2012). Impact of antithrombotic agents on prediction of thromboembolism with nonvalvular atrial fribrillation-A nationwide database analysis [master's thesis, National Central University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0031-1903201314450802
Omri, H. E., Taha, R. Y., Gamil, A., Ibrahim, F., Sabah, H. A., Mahmoud, Z. O., Pittari, G., jji, I. A. H., & Yassin, M. A. (2015). Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases. Clinical Medicine Insights: Blood Disorders, (2015), 1-7. https://doi.org/10.4137/CMBD.S25326
Moinat, C. H., Périard, D., Grueber, A., Hayoz, D., Magnin, J. L., André, P., Kung, M., & Betticher, D. C. (2014). Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients. Journal of Oncology, (2014), 130-135. https://doi.org/10.1155/2014/743181
Chang, P. Y., Ho, C. L., Chao, T. Y., Kao, W. Y., Dai, M. S., Chiueh, T. S., Wan, H. L., & Chen, Y. C. (2012). Diagnosis and Treatment of Thrombotic Thrombocytopenic Purpura: A Single Institution Experience. Journal of Medical Sciences, 32(3), 121-127. https://doi.org/10.6136/JMS.2012.32(3).121